ÂÜÀòÂÒÂ×

Simon Bucher is a Senior Scientist I at Scribe Therapeutics, with previous experience as a Postdoctoral Scholar at the University of California, San Francisco. Simon's research focuses on hepatoblastoma derived organoids culture, tissue dissociation, single cell RNA seq, single nuclei RNA seq, in situ hybridization, immunohistochemistry, and the role of Benzo[a]pyrene and alcohol on the progression of fatty liver toward steatohepatitis. Simon has a PhD in Cellular Biology and Toxicology from Université de Rennes I, a Master of Science in Cellular and Molecular Biology, and a Bachelor of Science in Biology.